Bucharest. 9 February 2024 – # RBJ (press release, Antibiotice) – – Antibiotice Iasi launches VetAria+, a range of nutritional supplements for veterinary use which complements our company’s veterinary prescription porfolio that, for decades, has been helping the vet professionals to treat various pathologies of our “non-speaking friends”. This development direction is part of our company’s portfolio expansion strategy, representing a source of future growth in the Antibiotice’s turnover.
“Today, Antibiotice launches a new business line, the veterinary supplements range, under the VetAria umbrella brand according to the business plan “The Future Together”. Our intention is to bring innovation in the pharmaceutical industry and market landscape. We take an important step between tradition and modernism, we start a new, innovative path, part of the current stage of portfolio modernization and fruition of a potential in new markets, with consolidated partnerships and new products. The desired growth objective to be achieved with this portfolio of veterinary products up to 2030, is to obtain 10% of the company’s turnover,“ declared Ovidiu Bataga, Executive Director – National Sales Unit, Antibiotice Iasi.
VetAria+ includes eight products manufactured on GMP authorized manufacturing flows (Good Manufacturing Practice), whose composition is unique in the Romanian market, containing ingredients with optimal therapeutic effects both in the prevention and improvement of symptoms specific to the pathologies for which they are intended. Also, the pharmaceutical form of these supplements meets the latest presentation trends, being twist-off capsules, easy to swallow, with different flavors, which ensure the quality and freshness of the ingredients.
Recommended in the treatment of the most common ailments of pets, dogs and cats, the nutritional supplements VetAria+ are available without a medical prescription and are used in the treatment of skin conditions, acute urinary tract conditions or infections, improving immunity, restoring and maintaining the intestinal flora, restoring and maintaining joint health, restoring and maintaining liver function, supporting kidney function.
The launch of the portfolio VetAria+ in the market will be carried out in the framework of scientific events accredited by the Romanian College of Veterinarians, which will be held in four cities, university centers in the country: Iasi, Bucuresti, Cluj, Timisoara.
The first event takes place in Iasi, on February 9, 2024 at the Antibiotice headquarters, where more than 150 veterinarians from the Moldova area are expected, representatives of the Faculty of Veterinary Medicine from Iasi.
During the events, scientific presentations related to pathologies, treatment and presentation of products will be given by outstanding personalities of veterinary medicine: dr. Conf. BOGDAN-ALEXANDRU VITALARU, qualified university lecturer at the Faculty of Veterinary Medicine in Bucharest, General Secretary of the Federation of European Companion Animal Veterinary Associations (FECAVA), dr. Conf. MIHAI MUSTEATA, university lecturer at the Faculty of Veterinary Medicine from Iasi, dr. RARES CAPITAN, veterinary doctor diploma, specialized in dermatology. Also, the team of specialists from Antibiotice will transmit detailed information regarding the new product portfolio that will be launched in the market under the VetAria+ brand.
“I am honored about the partnership with Antibiotice Iasi, one of the largest Romanian pharmaceutical companies, which has evolved over the decades into a symbol of excellence and I am happy to embark together with a partner of such stature on a journey that combines tradition, innovation and a common passion for health and pet welfare. VetAria+, the new line of veterinary supplements Antibiotice Iasi, combines this tradition with cutting-edge veterinary science. The commitment to excellence remains unwavering while carrying on the Antibiotice’s legacy of providing high quality pharmaceutical products. VetAria+ is further evidence of the desire to meet the evolving needs of veterinarians, pet owners and, most importantly, the four-legged patients,” declared dr. Conf. BOGDAN-ALEXANDRU VITALARU
Antibiotice aims, up to 2030s, to assimilate into the veterinary portfolio new products from various therapeutic classes: anti-infectious, anti-parasitic, anti-inflammatory, anti-thermic, anesthetic and even cosmetic products, which respond to the growing market demands for products intended to maintain health of pets.